BCLSI
NTRA icon

Bain Capital Life Sciences Investors’s Natera NTRA Stock Holding History

Bain Capital Life Sciences Investors’s Portfolio NTRA Stock Details NTRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-400,197
Closed -$25.1M – 27
2023
Q4 		$25.1M Sell
400,197
-300,000
-43% -$15M 2.4% 11
2023
Q3 		$31M Hold
700,197
– – 3.46% 9
2023
Q2 		$34.1M Hold
700,197
– – 3.51% 9
2023
Q1 		$38.9M Sell
700,197
-699,803
-50% -$33.6M 4.86% 5
2022
Q4 		$56.2M Buy
+1,400,000
New +$57.7M 6.28% 4

Other funds holding NTRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bain Capital Life Sciences Investors's NTRA Position: Q1 2024 in Review

Bain Capital Life Sciences Investors sold out of Natera (NTRA) in Q1 2024, closing a stake of 400,197 shares — an estimated $25.1M sold.

Bain Capital Life Sciences Investors first reported a position in NTRA in Q4 2022 and held it in 5 quarters. The position peaked at $56.2M in Q4 2022. 413 funds tracked by Wall St. Rank hold NTRA as of Q1 2024.

  • Bain Capital Life Sciences Investors reported no remaining Natera position as of Q1 2024 after selling out during the quarter.
  • Bain Capital Life Sciences Investors sold 400,197 Natera shares in Q1 2024, an estimated $25.1M.
  • Bain Capital Life Sciences Investors first reported a position in Natera in Q4 2022 and held it in 5 quarters.
  • Bain Capital Life Sciences Investors's Natera position peaked at $56.2M in Q4 2022.
  • 413 funds tracked by Wall St. Rank held Natera as of Q1 2024.

Based on Bain Capital Life Sciences Investors's 13F filing for Q1 2024, filed 15 May 2024.